Titanium, (S)-lactate polyethylene glycol triisopropanolamine ammonium complexes

Toxicity to reproduction

Administrative data

Endpoint:

one-generation reproductive toxicity

Remarks:

based on test guideline (migrated information)

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: Only limited details provided in NONS summary

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2000

Report date:

2000

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 415 [One-Generation Reproduction Toxicity Study (before 9 October 2017)]

Deviations:

no

GLP compliance:

yes

Limit test:

no

Test material

Test material information

Constituent 1

Reference substance name:

-

EC Number:

410-660-5

EC Name:

-

Cas Number:

1072830-14-8

Molecular formula:

Not Applicable for UVCB substance

IUPAC Name:

1-[bis(2-hydroxypropyl)amino]propan-2-ol 2-(rutherfordiooxy)ethan-1-ol 2-hydroxypropanoic acid amine titanium

Test animals

Species:

rat

Strain:

Sprague-Dawley

Sex:

male/female

Administration / exposure

Route of administration:

oral: unspecified

Vehicle:

water

Remarks:

Distilled water

Details on exposure:

Method of administration or exposure: Gavage
Mass median aerodynamic diameter: Not applicable

Frequency of treatment:

Dosing regime (males): 7 days/week
Dosing regime (females): 7 days/week

No. of animals per sex per dose:

Male: 28 animals at 0 mg/kg or mg/l
Male: 28 animals at 60 mg/kg or mg/l
Male: 28 animals at 300 mg/kg or mg/l
Male: 28 animals at 1200 mg/kg or mg/l
Female: 28 animals at 0 mg/kg or mg/l
Female: 28 animals at 60 mg/kg or mg/l
Female: 28 animals at 300 mg/kg or mg/l
Female: 28 animals at 1200 mg/kg or mg/l

Results and discussion

Results: P0 (first parental generation)

Details on results (P0)

Mortality:

At 1200 mg/kg 3 animals (2 males, 1 female) died as a result of dosing trauma.

At 300 mg/kg two females were found dead and one female was killed in extremis during the maturation phase of the study.
The deaths were consistent with dosing trauma.

At 30 mg/kg one male was killed in extremis during the mating phase of the study. Diuresis was observed on the day of termination. Post mortem observations included distension with haemorrhagic walls of the urinary bladder. In addition the prostrate was oedematous.

One female was killed in extremis during the lactation phase of the study. The deaths was consistent with dosing trauma.

At 0 mg/kg one male was killed in extremis during the post maturation phase of the study. On the day of termination there was clinical evidence of respiratory distress. Post mortem examination showed a jellified mass within the thorax.

Clinical observations:
There were no treatment-related clinical signs observed during the course of the study.

Bodyweight:
There were no significant treatment-related intergroup differences in male or female bodyweight gain.

Food consumption:
There were no significant treatment-related intergroup differences in male or female food consumption or food conversion.

Ophthalmoscopy:
There were no findings observed for selected males or females, either pretest or during week 10 of the study.

Laboratory Investigations:

Haematology:
There were no toxicologically significant intergroup differences in male or female blood haematological values.

Blood Chemistry:
There were no toxicologically significant intergroup differences in male or female blood chemistry values.

Reproductive Performance:

Fertility:

There were no significant treatment-related effects upon male or female mating or conception rates. The majority of pre-coital intervals were within the normal four to five day period. The distribution of pre-coital intervals were comparable for all groups.

Gestation and Parturition:

There were no significant treatment-related effects on the gestation or parturition indices. The distribution of gestation lengths were comparable for all groups, with the majority of gestation lengths being between twenty-two and twenty-three days.


Post Mortem Studies:

Necroscopy Findings:

There were no significant treatment-related intergroup differences in the type ro incidence of macroscopic anomalies observed for both males and females. The types of anomaly observed were those typically observed for this type of study.

Organ Weights:

There were no significant treatment-related intergroup differences for organ weights.


Histopathology:

At 1200 mg/kg there was a treatment-related effect on the stomachs of both males and females. Within the forestomach, subepithelial cell infiltrates, occasionally with associated acanthosis of the limiting ridge was observed. With the glandular stomach there was an increased incidence and
severity of agglomeration of secretion and goblet cell hyperplasia.

At 300 and 60 mg/kg there were no treatment-related effects on the stomach.

All the remaining morphological changes were those commonly observed in laboratory maintained rats of this age and strain.

Effect levels (P0)

1

Dose descriptor:

NOEL

Effect level:

ca. 300 mg/kg bw/day

Based on:

test mat.

Sex:

male/female

2

Dose descriptor:

NOEL

Remarks:

For reproductive performance

Effect level:

> 1 200 mg/kg bw/day

Based on:

test mat.

Sex:

male/female

Results: F1 generation

Details on results (F1)

Effects on F1 generation:
Litter Size, Sex and Offspring Viability:

There were no siginificant treatment-related intergroup
differences in the mean total number of offspring born.
Subsequent offspring viability throughout lactation was
comparable for all groups including controls. There were no
significant intergroup differences in the offspring sex
ratios at either days 1 or 21 of lactation.


Offspring Clinical Condition:

There were no significant treatment-related intergroup
differences in the type and incidence of clinical signs
observed for offspring throughout lactation. The clinical
signs were those commonly observed in this type of study.


Offspring Bodyweight and Development:

There were no significant treatment-related intergroup
differences in both the mean total litter weight or mean
individual offspring bodyweight throughout lactation. There
were no significant treatment-related intergroup differences
in offspring maturation, as denoted by the onset and
completion of landmarks of development, throughout
lactation.


Offspring Reflexological Assessment:

There were no significant treatment-related intergroup
differences in offspring reflexological responses.


Offspring Necroscopy Findings:

There were no significant treatment-related intergroup
differences in the incidence and type of observations seen
at post mortem examination of offspring from either the
imterim and terminal necroscopy. The type of findings are
those commonly observed for this study type.

Overall reproductive toxicity

Reproductive effects observed:

not specified

Applicant's summary and conclusion

Conclusions:

At a dose level of 1200 mg TILCOM AT35/kg bodyweight there was a minor histopathological effect upon the stomachs of both males and females. There was no effect on either sex during the in-life phase of the study and no effect on either reproductive performance or offspring growth and survival. The no effect level for adult toxicity was therefore 300 mg TILCOM AT35/kg bodyweight. The no effect level for reproductive performances was in excess of 1200 mg TILCOM AT35/kg bodyweight.